Hyaluronan as an immune regulator in human diseases
Accumulation and turnover of extracellular matrix components are the hallmarks of tissue
injury. Fragmented hyaluronan stimulates the expression of inflammatory genes by a variety …
injury. Fragmented hyaluronan stimulates the expression of inflammatory genes by a variety …
Pulmonary fibrosis: patterns and perpetrators
PW Noble, CE Barkauskas… - The Journal of clinical …, 2012 - Am Soc Clin Investig
Pulmonary fibrosis occurs in a variety of clinical settings, constitutes a major cause of
morbidity and mortality, and represents an enormous unmet medical need. However, the …
morbidity and mortality, and represents an enormous unmet medical need. However, the …
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
MW Parker, D Rossi, M Peterson… - The Journal of …, 2014 - Am Soc Clin Investig
Pathological remodeling of the extracellular matrix (ECM) by fibroblasts leads to organ
failure. Development of idiopathic pulmonary fibrosis (IPF) is characterized by a progressive …
failure. Development of idiopathic pulmonary fibrosis (IPF) is characterized by a progressive …
[HTML][HTML] Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
S Piera-Velazquez, Z Li, SA Jimenez - The American journal of pathology, 2011 - Elsevier
The accumulation of a large number of myofibroblasts is responsible for exaggerated and
uncontrolled production of extracellular matrix during the development and progression of …
uncontrolled production of extracellular matrix during the development and progression of …
Hyaluronan as a therapeutic target in human diseases
Accumulation and turnover of extracellular matrix is a hallmark of tissue injury, repair and
remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix …
remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix …
[HTML][HTML] Strategies for anti-fibrotic therapies
J Rosenbloom, FA Mendoza, SA Jimenez - Biochimica et Biophysica Acta …, 2013 - Elsevier
The fibrotic diseases encompass a wide spectrum of entities including such multisystemic
diseases as systemic sclerosis, nephrogenic systemic fibrosis and sclerodermatous graft …
diseases as systemic sclerosis, nephrogenic systemic fibrosis and sclerodermatous graft …
WNT signaling in lung disease: a failure or a regeneration signal?
M Königshoff, O Eickelberg - American journal of respiratory cell …, 2010 - atsjournals.org
The WNT family of signaling proteins is essential to organ development in general and lung
morphogenesis in particular. Originally identified as a developmentally active signaling …
morphogenesis in particular. Originally identified as a developmentally active signaling …
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
B Mehrad, MD Burdick, DA Zisman, MP Keane… - Biochemical and …, 2007 - Elsevier
Fibrotic interstitial lung diseases are illnesses of unknown cause characterized by
progressive decline in lung function. Fibrocytes are bone marrow-derived, circulating …
progressive decline in lung function. Fibrocytes are bone marrow-derived, circulating …
Transforming growth factor (TGF)-β1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, Bid-activated pathway that involves matrix …
HR Kang, SJ Cho, CG Lee, RJ Homer… - Journal of Biological …, 2007 - ASBMB
Fibrosis, apoptosis, and the exaggerated production of transforming growth factor (TGF)-β 1
are juxtaposed in a variety of pulmonary diseases including the interstitial lung diseases and …
are juxtaposed in a variety of pulmonary diseases including the interstitial lung diseases and …
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Pulmonary fibrosis is a progressive, dysregulated response to injury culminating in
compromised lung function due to excess extracellular matrix production. The heparan …
compromised lung function due to excess extracellular matrix production. The heparan …